A prospective study of artificially sweetened beverage intake and cardiometabolic health among women at high risk

Stefanie N. Hinkle*, Shristi Rawal, Anne Ahrendt Bjerregaard, Thor I. Halldorsson, Mengying Li, Sylvia H. Ley, Jing Wu, Yeyi Zhu, Liwei Chen, Aiyi Liu, Louise Groth Grunnet, Mohammad L. Rahman, Freja Bach Kampmann, James L. Mills, Sjurdur F. Olsen, Cuilin Zhang

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

70 Downloads (Pure)

Abstract

Background: Artificially sweetened beverages (ASBs) are commonly consumed and recommended for individuals at high risk for cardiometabolic diseases; however, the health effects of ASBs remain contradictory. Given that cross-sectional analyses are subject to reverse causation, prospective studies with long-term follow-up are needed to evaluate associations between ASBs and cardiometabolic health, especially among high-risk individuals. Objective: The aim of this studywas to examine associations of ASB intake and cardiometabolic health among high-riskwomenwith prior gestational diabetes mellitus (GDM). Methods: We included 607 women with GDM from the Danish National Birth Cohort (DNBC; 1996-2002) who completed a clinical exam 9-16 y after the DNBC pregnancy for the Diabetes & Women's Health (DWH) Study (2012-2014). We assessed ASB intake using FFQs completed during the DNBC pregnancy and at the DWH Study clinical exam. We examined cardiometabolic outcomes at the DWH clinical exam. We estimated percentage differences in continuous cardiometabolic markers and RRs for clinical endpoints in association with ASB intake both during pregnancy and at follow-up adjusted for prepregnancy BMI, diet, and lifestyle factors. Sensitivity analyses to account for reverse causation were performed. Results: In pregnancy and at follow-up, 30.4% and 36.4% of women regularly (≥2 servings/wk) consumed ASB, respectively. Consumption of ASBs, both during pregnancy and at follow-up, was associated with higher glycated hemoglobin (HbA1c), insulin, HOMA-IR, triglycerides, liver fat, and adiposity and with lower HDL at follow-up. After adjustment for covariates, particularly prepregnancy BMI, the majority of associations between ASB intake in pregnancy and outcomes at follow-up became null with the exception of HbA1c. ASB intake at follow-up (≥1 serving/d compared with <1 serving/mo) was associated with higher HbA1c (6.5%; 95% CI: 1.9, 11.3; P-trend = 0.007); however, associations were not upheld in sensitivity analyses for reverse causation. Conclusions: Among Danish women with a history of GDM, ASB intake was not significantly associated with cardiometabolic profiles.

Original languageEnglish
Article numbernzq094
JournalThe American Journal of Clinical Nutrition
Volume110
Issue number1
Pages (from-to)221-232
ISSN0002-9165
DOIs
Publication statusPublished - 2019

Keywords

  • Artificially sweetened beverages
  • Cardiometabolic health
  • Diabetes
  • Diet
  • Gestational diabetes
  • Nonnutritive sweeteners
  • Obesity
  • Soda

Fingerprint

Dive into the research topics of 'A prospective study of artificially sweetened beverage intake and cardiometabolic health among women at high risk'. Together they form a unique fingerprint.

Cite this